TransMedics Group Inc vs Vanguard S&P 500 ETF — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Vanguard S&P 500 ETF trades at $687.43. The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | VOO | |
|---|---|---|
Market Cap | $2.54B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $150.42 | $698.29 |
52-Week Low | $61.99 | $571.45 |
Enterprise Value | $2.94B | — |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →